Gurugram-based Zoplar, a platform aimed at streamlining the medical equipment procurement process for small and medium-sized hospitals in India, has raised $3.4 million in a Series A funding round. The round was led by Blume Ventures, with participation from Beenext, Saison Capital, Atrium Angels, Finfirst, and LogX. This latest investment brings the total funding secured by the company to $5.1 million, with prior contributions from Titan Capital, Stride Ventures, and Panthera Peak.
Zoplar plans to use the funds to enhance its operational capabilities by focusing on backward integration in the supply chain and building a service engineering team. India’s healthcare infrastructure is undergoing rapid transformation, and MSME hospitals play a critical role in bridging existing gaps. However, these hospitals often face challenges in identifying cost-effective medical equipment, managing vendor relationships, ensuring quality after-sales service, and securing financing solutions.
Zoplar is addressing these issues by developing a full-stack medical equipment platform tailored to meet the needs of MSME hospitals.
Funding for medical equipment platform
Co-founders Amit Sah and Umesh Sharma launched Zoplar in 2022 after identifying these pain points through research.
Drawing on their previous collaboration at OYO, the duo combined their expertise in healthcare and operations to create a platform that simplifies the medtech procurement and after-sales experience for MSME hospitals. “This investment is not just financial backing—it’s a validation of our mission to make quality healthcare accessible through affordable and reliable medical technologies. It motivates us to scale our impact, enhance our offerings, and continue empowering healthcare providers to deliver uninterrupted care,” said Amit Sah and Umesh Sharma, co-founders of Zoplar.
Since its inception, Zoplar claims to have partnered with over 300 hospitals, including leading nephrology chains like DCDC, and boasts a 40% repeat customer rate. This underscores the demand for its solutions in India’s evolving healthcare sector. Sajith Pai, VC at Blume Ventures, highlighted, “We believe in Zoplar’s vision and their capacity to improve India’s healthcare landscape.
Their commitment to addressing critical procurement and service challenges aligns with our focus on ventures driving meaningful societal change.”
This investment marks a milestone in Zoplar’s journey to revolutionize the medtech procurement space and strengthen the capabilities of MSME hospitals across India.